Protein Buildup in ALS Brains Linked to Lower Protein Removal Factor
Researchers at Torrey Pines Institute for Molecular Studies, in Florida, discovered that patients with amyotrophic lateral sclerosis (ALS) have lower…
Articles by Magdalena Kegel
Researchers Find ‘Harmful’ ALS Factor Actually Protects Neurons from Inflammation
Attempting to lower a specific protein that is higher in patients with amyotrophic lateral sclerosis (ALS), researchers discovered that the protein does not contribute to…
Promising ALS Biomarkers Identified Through Protein Screening in Chinese Study
By screening nearly 250 factors in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS), Chinese researchers were able to…
ALS Severity, Likely Progression May Be Evident in 2 of Brain’s ‘Resting State’ Networks
Activity seen in two of the brain’s resting state networks in amyotrophic lateral sclerosis (ALS) patients may be a sign of…
Copper Abnormalities in ALS Linked to SOD1 Mutations Merit Human Studies, Review Suggests
Mutations in the SOD1 gene, a major copper-binding protein, are a known cause of familial amyotrophic lateral sclerosis (ALS). An extensive…
Protein Aggregates Seen to Rapidly Spread in Mice with Hereditary ALS Mutation
SOD1 protein aggregates can spread in a prion-like way, rapidly causing amyotrophic lateral sclerosis (ALS) when injected into the spinal…
Tiny Microscope Lets Scientists Peer into Spinal Cords of Mice and See Astrocytes in Action
Researchers using a miniature microscope saw that glial cells, called astrocytes, contribute to sensory nerve transmission in the spinal cord of…
Teenagers in Published Study Find Maple Syrup Protected Motor Neurons in an ALS Model
An after-school study by two teenagers in Canada found that maple syrup protects neurons and halts the development of amyotrophic lateral sclerosis…
AB Science Reviews Ongoing Phase 3 Study of Masitinib as ALS Treatment in Conference with Experts
AB Science recently reported positive data from an interim analysis of a Phase 2/3 study of masitinib, its lead compound to…
Herantis’ Potential ALS Treatment, CDNF, Recommended for Orphan Drug Status by EMA
Herantis Pharma announced that it has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products…